(888) 352-RUSH for help arranging an appointment.
Faculty Rank: Assistant Professor
Medical or Graduate Education:
Rush Medical College
Rush University Medical Center - Internal Medicine
Rush University Medical Center - Hematology/Oncology
Soft tissue sarcoma
Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.
Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer. Dandekar VK, Young J, Kiel K, Bonomi P, Fidler MJ, Batus M, Sher DJ Am. J. Clin. Oncol. 2014 Apr 28 Optimal management of metastatic melanoma: current strategies and future directions. Batus M, Waheed S, Ruby C, Petersen L, Bines SD, Kaufman HL. Am J Clin Dermatol. 2013 2013 Jun 14(3):179-94. doi: 10.1007/s40257-013-0025-9. Future directions for pediatric and young adult bone sarcoma. Finney J, Kent PM, Batus M Curr Probl Cancer 2013 Jul-Aug 37(4):225-35. Utility of insulin-like growth factor receptor-1 expression in gefitinib-treated patients with non-small cell lung cancer. Fidler MJ, Basu S, Buckingham L, Walters K, McCormack S, Batus M, Coon J 4th, Bonomi P. Anticancer Res. 2012 2012 May 32(5):1705-10. Prognostic Significance of Weight Gain During Definitive Chemoradiotherapy for Locally Advanced Non-Small-Cell Lung Cancer. Sher DJ, Gielda BT, Liptay MJ, Warren WH, Batus M, Fidler MJ, Garg S, Bonomi P. Clin Lung Cancer. 2012 2012 Dec 20. doi:pii: S1525-7304(12)00263-X. 10.1016/j.cllc.2012.10.009. [Epub ahead of print] Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients. Gielda BT, Marsh JC, Zusag TW, Faber LP, Liptay M, Basu S, Warren WH, Fidler MJ, Batus M, Abrams RA, Bonomi P. J Thorac Oncol. 2011 2011 Jun 6(6):1079-86. doi: 10.1097/JTO.0b013e3182199a7c. Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer. Kim AW, Batus M, Myint R, Fidler MJ, Basu S, Bonomi P, Faber LP, Wightman SC, Warren WH, McIntire M, Arvanitis LD, Gattuso P, Xu X, Liptay MJ. Lung Cancer. 2011 2011 Feb 71(2):186-90. doi: 10.1016/j.lungcan.2010.05.006. Epub 2010 Jun 8. Primary and secondary therapeutic strategies for EGF receptor pathway inhibition in non-small-cell lung cancer. Batus M, Fidler MJ, Bonomi PD. Expert Rev Anticancer Ther. 2010 2010 Oct 10(10):1589-99. doi: 10.1586/era.10.104. Review. Neoadjuvant treatment of rectal gastrointestinal stromal tumors with imatinib. Turner J, Batus M, Leslie W, Coogan C, Saclarides TJ. Am Surg. 2010 2010 Aug 76(8):E110-2. No abstract available. Idiopathic hemophagocytic syndrome with a fulminant clinical course. Khandelwal A, Shah NB, Eichenseer P, Welker M, Miller I, Nangia J, Farhat M, Gimelfarb A, Kassar M, Batus M, Gezer S, Shammo J, Gregory S, Fung H, Venugopal P. Clin Adv Hematol Oncol. 2008 2008 Aug 6(8):587-90. Review. No abstract available.
To watch a brief video of Marta Batus, MD, click the play button at the lower left corner of the video frame below.
(If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
My practice includes very complicated patients — patients mostly with lung cancer, sarcomas and melanoma.
I’m very committed to my patients, and I think my patients know that. I know it’s very important to not only treat the patient, but also their families. So I also like to include them in the decision making and taking care of the patient as well.
It’s truly a privilege to be an oncologist, and the most gratifying part of oncology is the patient-physician relationship that we establish with our patients.